Comparative mutagenic and genotoxic effects of three antimalarial drugs, chloroquine, primaquine and amodiaquine

Mutagenesis

Volumn 13, Issue 6, 1998, Pages 619-624

  Chatterjee, Taraknath ^a   Muhkopadhyay, Amitabha ^a   Khan, Kalim A ^b   Giri, Ashok K ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; CHLOROQUINE; PRIMAQUINE;

ANIMAL TISSUE; ARTICLE; CHEMICAL MUTAGENESIS; CHROMOSOME ABERRATION; CONTROLLED STUDY; GENOTOXICITY; MALE; MOUSE; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; SISTER CHROMATID EXCHANGE;

EID: 0031726186     PISSN: 02678357     EISSN: None     Source Type: Journal    
DOI: 10.1093/mutage/13.6.619     Document Type: Article

References (49)

1. Ames,B. and Whitfield,H.,Jr (1966) Frame shift mutagenesis in Salmonella. Cold Spring Harbor Symp. Quant. Biol., 31, 221-225.
2. Bruce-Chwatt,L.J. (1986) Chemotherapy of Malaria, Revised 2nd Edn. WHO Monograph Series no. 27, WHO, Geneva, Switzerland, pp. 61-64.
3. Cohen,R.J., Sachs,J.R., Wicker,D.J. and Courad,M.E. (1986) Methemoglobinemia provoked by malarial chemoprophylaxis in Vietnam. New Engl. J. Med., 279, 1127-1131.
4. Cohen,S.N. and Yielding,K.L. (1965) Spectrophotometer studies of the interaction of chloroquine with deoxyribonucleic acid. J. Biol. Chem., 240, 3123-3131.
5. Cortinas de Nava,C., Espinosa,J., Garcia,L., Zapata,A.M. and Martinez,E. (1983) Mutagenicity of antiamebic and anthelmintic drugs in the Salmonella typhimurium test system. Mutat. Res., 117, 79-91.
6. Dunnett,C.W. (1955) A multiple comparison procedure for comparing several treatments with the control. J. Am. Statist. Assoc., 50, 1096-1121.
7. Espinosa-Aguirre,J.J., Ramirez Santos,J. and Cortinas de Nava,C. (1989) Influence of the Uvr repair system on the mutagenicity of antiparasitic drugs. Mutat. Res., 222, 161-166.
8. Field,R.C., Bibson,B.R., Holbrook,D.J.,Jr and McCall,B.N. (1978) Inhibition of precursor incorporation into nucleic acids of mammalian tissues by antimalarial aminoquinolins. Br. J. Pharmacol., 62, 159-164.
9. Garner,R.C., Miller,E.C. and Miller,J.A. (1972) Liver microsomal metabolism of aflatoxin B1 to a reactive derivative toxic to Salmonella typhimurium TA1530. Cancer Res., 32, 2085-2066.
10. Ghosh,M.N. (1984) Fundamentals of Experimental Pharmacology, 2nd Edn. Scientific Book Agency, Calcutta, India, pp. 155.
11. Giri,A.K. (1996) Genetic toxicology of four commonly used benzodiazepines: a review. Mutat. Res., 340, 93-108.
12. Giri,A.K. (1997) Genetic toxicology of epichlorohydrin: a review. Mutat. Res., 386, 25-38.
13. Giri,A.K., Messerly,E.A. and Sinsheimer,J.E. (1989) Sister chromatid exchange and chromosome aberrations for four aliphatic epoxides in mice. Mutat. Res., 224, 253-261.
14. Giri,A.K., Sai Sivam,S. and Khan,K.A. (1992) Sister chromatid exchange and chromosome aberrations induced by paracetamol in vivo in bone marrow cells of mice. Mutat. Res., 278, 253-257.
15. 2 in rodents. Mutat. Res., 306, 151-156.
16. Goodman,X.S. and Gilman,A. (1980) Drugs used in the chemotherapy of malaria. In Goodman,L.S. and Gilman,A. (eds), The Pharmacological Basis of Therapeutics, 6th edn. Macmillan Publishing Co. Inc., New York, pp. 1038-1060.
17. Hakura,A., Tsutsui,Y., Mochida,H., Sugihara,Y., Mikami,T. and Sagami,F. (1996) Mutagenicity of dihydroxy benzenes and dihydroxy naphthalenes for Ames Salmonella tester strains. Mutat. Res., 371, 293-299.
18. Henry,D.W. (1973) Acridine antimalarials. In Acheson,R-M. (ed.), Acridines, 2nd Edn. Wiley, New York, NY, pp. 829-850.
19. Ivett,J.L. and Tice,R.R. (1982) Average generation time: a new method for analyzing cellular proliferation kinetics based on bromodeoxyuridine-dependent chromosome differential staining patterns. Environ. Mutagen., 4, 358-365.
20. Kadotani,S., Arisawa,M. and Maruyama,H.B. (1984) Mutagenicity examination of several non steroidal anti-inflammatory drugs in bacterial systems. Mutat. Res., 138, 133-136.
21. Levin,D.E., Hollstein., Christman,M.F., Schwiers,E.A. and Ames,B.A. (1982) A new tester strain (TA102) with A-T base pairs at the site of mutation detects oxidative mutagens. Proc. Natl Acad. Sci. USA, 79, 7445-7449.
22. Linquist,N.G. (1973) Accumulation of drugs on melanin. Acta. Radial., 325 (suppl.), 1-92.
23. Marnett,L.J., Hurd,H.K., Hollstein,M.C., Levin,D.E., Esterbauer,H. and Ames,B.N. (1985) Naturally occuring carbonyl compounds are mutagens in Salmonella tester strain TA104. Mutat. Res., 148, 25-34.
24. Maron,D.M. and Ames,B.N. (1983) Revised methods for Salmonella mutagenicity test. Mutat. Res., 113, 173-215.
25. Marrs,T.C., Bright,J.E. and Morris,B.C. (1987) Methemoglobinogenic potential of primaquine and its mutagenicity in Ames test. Toxicol. Lett., 36, 281-287.
26. Martindale,H. (1996) Martindale The Extra Pharmacopoeia. J.E.F.Reynolds (ed.). The Pharmaceutical Press, London, UK, p. 464.
27. McChesney,E.W. and McAnliff,J.P. (1961) Laboratory studies of the four aminoquinolin antimalarials. I. Some biochemical characteristics of chloroquine, hydrochloroquine and SN-7718. Antibiot. Chemother., 11, 800-810.
28. McChesney,E.W., Banks,W.F.,Jr and Fabian,R.J. (1967) Tissue distribution of Chloroquine, hydroxychloroquine and desethyl chloroquine in the rat. Toxicol. Appl. Pharmacol., 10, 501-513.
29. McFee,A.F., Lowe,K. and San Sebastian,J.R. (1983) Improved sister chromatid differentiation using paraffin coated bromodeoxyuridine tablets in mice. Mutat. Res., 119, 83-88.
30. Michael,R.O. and William,G.M. (1974) Chloroquine inhibition of repair of DNA damage induced in mammalian cells by methyl methane sulphonate. Mutat. Res., 25, 391-396.
31. Obaseiki-Ebor,E.E. and Obasi,E.E. (1986) Aspects of chloroquine mutagenicity. Mutat. Res., 175, 51-59.
32. Ono,T., Norimatsu,M. and Yoshimura,H. (1994) Mutagenic evaluation of primaquine, pentaquine and pamaquine in the Salmonella/mammalian microsome assay. Mutat. Res., 325, 7-10.
33. Perry,P. and Wolff,S. (1974) New Giemsa method for the differential staining of sister chromatids. Nature, 251, 156-158.
34. Philipose,B., Singh,R., Khan,A.K. and Giri,A.K. (1997) Comparative mutagenic and genotoxic effects of three propionic acid derivatives ibuprofen, ketoprofen and naproxen. Mutat. Res., 393, 123-131.
35. Preston,R.J., Dean,B.J., Galloway,S., Holden,H., McFee,A.F. and Shelby,M. (1987) Mammalian in vivo cytogenetic assays: analysis of chromosome aberrations in bone marrow cells. Mutat. Res., 189, 157-165.
36. Raj,S.A. and Heddle,J.A. (1980) Simultaneous detection of chromosomal aberrations and sister chromatid exchange: experience with DNA intercalating agents. Mutat. Res., 78, 253-260.
37. Reever,P.A., Toalin,H., Kaneko,A., Hall,J.J. and Ganczakowski,M. (1992) Acute intramuscular haemolysis in vanuater following a single dose of primaquine in individuals with glucose-6-phosphate deficiency. J. Trop. Med. Hyg., 95, 349-351.
38. Schupbach,M.E. (1979) Mutagenicity evaluation of the two antimalarial agents chloroquine and mefloquine using a bacterial fluctuation test. Mutat. Res., 68, 41-49.
39. Sharief,Y., Brown,A.M., Backer,L.C., Campbell,A.J., Westbrook-Collins,B., Stead,A.G. and Allen,J.W. (1986) Sister chromatid exchange and chromosome aberration analyses in mice after in vivo exposure to acrylonitrile, styrene, or butadiene monoxide. Environ. Mutagen., 8, 439-448.
40. Sharma,A. and Rawat,A.K. (1989) Toxicological consequences of chloroquine and ethanol on the developing foetus. Pharmacol. Biochem. Behav., 34, 77-82.
41. Shubber,E.K., Jacobson-Kram,D. and Williams,J.R. (1986) Comparison of the Ames assay and the induction of sister chromatid exchanges: results with ten pharmaceuticals and five selected agents. Cell. biol. Toxicol., 2, 379-399.
42. Sternglanz,H., Yielding,K.C. and Pruitt,K.M. (1969) Nuclear magnetic resonance studies of the interaction of chloroquine diphosphate with adenosine diphosphate and other nucleotides. Mol. Pharmacol., 5, 376-381.
43. Thomas,S.M., Silburn,K.A. and MacPhee,D.G. (1987) Frameshift mutagenesis by chloroquine in E coli and S. typhimurium. Mutat. Res., 192, 233-237.
44. Waring,M. (1970) Variation of the supercoils in closed circular DNA by binding of antibiotics and drugs. Evidence for molecular models involving interaction. J. Mol. Biol., 54, 247-279.
45. White,N.J. and Breman,J.G. (1998) Malaria and other diseases caused by red blood cell parasites. In Fauci,A., Braunwald,E., Isselbacher,K.J., Wilson,J.D., Martin,J.B., Kasper,D.L., Hauser,S.L. and Longo,D.L. (eds), Harrison's Principles of Internal Medicine, 14th Edn. McGraw-Hill, New York, NY, Vol. 1, p. 1187.
46. Wichard,L.P., Washington,M.E. and Holbrook,D.J.,Jr (1972) The inhibition in vitro of bacterial DNA polymerase and RNA polymerase by antimalarial 8-aminoquinolines and by chloroquine. Biochim. Biophys. Acta, 287, 52-67.
47. World Health Organization (1985) Environmental Health Criteria, Vol. 46, Guidelines for the Study of Genetic Effects in Human Populations. WHO, Geneva, Switzerland.
48. Xamena,N., Creus,A., Velazqez,A. and Marcos,R. (1985) Testing of chloroquine and quinacrine for mutagenicity in Drosophila melanogater. Mutat. Res., 158, 177-180.
49. Yielding,K.L., Yielding,L. and Gaudin,D. (1970) Inhibition by chloroquine of UV repair in E. coli B. Proc. Soc. Exp. Biol. Med., 133, 99-101.